Ferdinand Groenewald's Insider Trades & SAST Disclosures

Ferdinand Groenewald's most recent trade in Biosig Technologies Inc was a trade of 35,000 Common Stock done . Disclosure was reported to the exchange on April 24, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Biosig Technologies Inc
Ferdinand Groenewald Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2025 35,000 60,000 (0%) 0% 0 Common Stock
Alaunos Therapeutics Inc
Ferdinand Groenewald VP, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2025 3,000 3,000 - - Employee Stock Option (right to buy)
Alaunos Therapeutics Inc
Ferdinand Groenewald VP, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Aug 2024 1,500 1,500 - - Employee Stock Option (right to buy)
Sadot Group Inc
Ferdinand Groenewald Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2022 25,000 25,000 - - Stock Options
Sadot Group Inc
Ferdinand Groenewald Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 0.58 per share. 15 Feb 2022 19,285 0 - 0.6 11,185 Common Stock
Sadot Group Inc
Ferdinand Groenewald Chief Financial Officer Grant, award, or other acquisition of securities at price $ 2.87 per share. 11 Feb 2021 19,285 19,285 - 2.9 55,348 Common Stock
Sadot Group Inc
Ferdinand Groenewald Chief Financial Officer Other type of transaction at price $ 0.00 per share. 24 Jul 2020 19,285 0 - 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades